Vericel (VCEL) Accumulated Expenses (2010 - 2026)
Vericel's (VCEL) quarterly Accumulated Expenses came in at $14.0 million in Q1 2026, up 22.32% year-on-year from $11.4 million in Q1 2025, and down 27.39% quarter-over-quarter from $19.2 million in Q4 2025.
Vericel (VCEL) Accumulated Expenses (2010 - 2026) Analysis & Trends
Vericel has disclosed Accumulated Expenses across 17 years of filings, most recently posting $14.0 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $14.0 million, up 22.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (up 22.32% YoY), and the FY2025 annual result was $19.2 million, up 12.72% from the prior year.
- Accumulated Expenses came in at $14.0 million for Q1 2026 at Vericel, down from $19.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $19.2 million in Q4 2025 to a low of $10.8 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $14.0 million (2026), against an average of $14.2 million.
- Across the five-year window, Accumulated Expenses rose 27.59% in 2022 and slipped 15.9% in 2024, its largest moves.
- Vericel's Accumulated Expenses stood at $16.2 million in 2022, then grew by 6.33% to $17.2 million in 2023, then slipped by 0.87% to $17.1 million in 2024, then increased by 12.72% to $19.2 million in 2025, then retreated by 27.39% to $14.0 million in 2026.
- The last three Accumulated Expenses figures came in at $14.0 million (Q1 2026), $19.2 million (Q4 2025), and $16.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.97 Mn |
| Dec 31, 2025 | 19.24 Mn |
| Sep 30, 2025 | 16.29 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 11.42 Mn |
| Dec 31, 2024 | 17.07 Mn |
| Sep 30, 2024 | 14.34 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | 13.63 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 13.11 Mn |
| Dec 31, 2022 | 16.19 Mn |
| Sep 30, 2022 | 13.95 Mn |
| Jun 30, 2022 | 12.13 Mn |
| Mar 31, 2022 | 10.79 Mn |
| Dec 31, 2021 | 14.05 Mn |
| Sep 30, 2021 | 10.93 Mn |
| Jun 30, 2021 | 11.08 Mn |